Filed: 8/8/2024ACC: 0001766721-24-000004
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $231.05M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$231.05M
Total AUM (reported)
20.39M
Total Shares
Allocation by class
COM$197.91M85.7%
SPONSORED ADS$21.95M9.5%
COM CL A$7.42M3.2%
COM NEW$3.77M1.6%
Portfolio Concentration
Top 3$190.88M82.6%
4–10$35.11M15.2%
11–25$5.07M2.2%
Top 3 weight
82.6%
Top 10 weight
97.8%
Voting Authority Distribution
Total shares with voting rights: 20.39M
Sole
Full voting authority
20.39M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings15
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$153.71M
66.52%
Sole
6.07M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$21.04M
9.11%
Sole
1.02M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.12M
TypeSH
Market value$16.13M
6.98%
Sole
1.12M
Shared
0.00
None
0.00
Elevation Oncology Inc (ELEV)
SOLEShares2.83M
TypeSH
Market value$7.65M
3.31%
Sole
2.83M
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$7.42M
3.21%
Sole
2.54M
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares964.50K
TypeSH
Market value$5.83M
2.52%
Sole
964.50K
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$5.51M
2.38%
Sole
1.47M
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares798.76K
TypeSH
Market value$3.59M
1.56%
Sole
798.76K
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$3.05M
1.32%
Sole
1.04M
Shared
0.00
None
0.00
CalciMedica, Inc. (CALC)
SOLEShares521.11K
TypeSH
Market value$2.06M
0.89%
Sole
521.11K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares314.29K
TypeSH
Market value$1.71M
0.74%
Sole
314.29K
Shared
0.00
None
0.00
Tectonic Therapeutic Inc (TECX)
SOLEShares84.15K
TypeSH
Market value$1.39M
0.60%
Sole
84.15K
Shared
0.00
None
0.00
Reneo Pharmaceuticals Inc (RPHM)
SOLEShares886.08K
TypeSH
Market value$1.34M
0.58%
Sole
886.08K
Shared
0.00
None
0.00
Aclaris Therapeutics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$477.9K
0.21%
Sole
434.45K
Shared
0.00
None
0.00
Viracta Therapeutics Inc (VIRX)
SOLEShares288.57K
TypeSH
Market value$156.9K
0.07%
Sole
288.57K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $153.71M 66.52% | 6.07M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $21.04M 9.11% | 1.02M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.12M | SH | $16.13M 6.98% | 1.12M | 0.00 | 0.00 |
Elevation Oncology Inc (ELEV)SOLE | COM | 2.83M | SH | $7.65M 3.31% | 2.83M | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $7.42M 3.21% | 2.54M | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 964.50K | SH | $5.83M 2.52% | 964.50K | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $5.51M 2.38% | 1.47M | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 798.76K | SH | $3.59M 1.56% | 798.76K | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $3.05M 1.32% | 1.04M | 0.00 | 0.00 |
CalciMedica, Inc. (CALC)SOLE | COM NEW | 521.11K | SH | $2.06M 0.89% | 521.11K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM NEW | 314.29K | SH | $1.71M 0.74% | 314.29K | 0.00 | 0.00 |
Tectonic Therapeutic Inc (TECX)SOLE | COM | 84.15K | SH | $1.39M 0.60% | 84.15K | 0.00 | 0.00 |
Reneo Pharmaceuticals Inc (RPHM)SOLE | COM | 886.08K | SH | $1.34M 0.58% | 886.08K | 0.00 | 0.00 |
Aclaris Therapeutics Inc (ACRS)SOLE | COM | 434.45K | SH | $477.9K 0.21% | 434.45K | 0.00 | 0.00 |
Viracta Therapeutics Inc (VIRX)SOLE | COM | 288.57K | SH | $156.9K 0.07% | 288.57K | 0.00 | 0.00 |